XML 39 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 2 - Restatement of Previously Issued Financial Statements - Summary of Effects of Restatements (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 30, 2017
Dec. 31, 2016
Mar. 31, 2017
Net Sales $ 387,689 $ 356,767 $ 1,015,086 $ 981,508  
Cost of Products Sold 357,188 318,841 951,639 890,602  
Gross Profit 30,501 37,926 63,447 90,906  
Operating Income/(Loss) 10,271 14,341 9,475 29,933  
Earnings/(Loss) Before Income Taxes 6,259 12,260 (1,166) 23,724  
Income Tax (Benefit) Expense 1,882 4,471 (1,605) 8,149  
Net earnings $ 4,377 $ 7,789 $ 439 $ 15,575  
Earnings Per Common Share-Basic (in dollars per share) $ 0.45 $ 0.79 $ 0.04 $ 1.58  
Earnings Per Common Share-Diluted (in dollars per share) $ 0.44 $ 0.78 $ 0.04 $ 1.57  
Inventory $ 770,702 $ 699,445 $ 770,702 $ 699,445 $ 628,935
Total Current Assets 855,094 793,233 855,094 793,233 719,149
Total Assets 1,134,237 1,053,746 1,134,237 1,053,746 978,268
Deferred Revenue 80,151 60,553 80,151 60,553 46,100
Total Current Liabilities 242,033 238,771 242,033 238,771 177,764
Total Liabilities 711,832 647,136 711,832 647,136 553,064
Stockholders' Equity 422,405 406,610 422,405 406,610 425,204
Total Liabilities and Stockholders' Equity 1,134,237 1,053,746 1,134,237 1,053,746 978,268
Previously Reported [Member]          
Net Sales 392,714 369,705 1,049,209 979,566  
Cost of Products Sold 361,013 332,230 981,344 891,904  
Gross Profit 31,701 37,475 67,865 87,662  
Operating Income/(Loss) 11,471 13,890 13,893 26,689  
Earnings/(Loss) Before Income Taxes 7,459 11,809 3,252 20,480  
Income Tax (Benefit) Expense (268) 3,628 (2,524) 6,217  
Net earnings $ 7,727 $ 8,181 $ 5,776 $ 14,263  
Earnings Per Common Share-Basic (in dollars per share) $ 0.79 $ 0.83 $ 0.59 $ 1.44  
Earnings Per Common Share-Diluted (in dollars per share) $ 0.78 $ 0.82 $ 0.58 $ 1.43  
Inventory $ 710,118 $ 656,368 $ 710,118 $ 656,368 598,056
Total Current Assets 794,510 750,156 794,510 750,156 688,270
Total Assets 1,072,003 1,004,711 1,072,003 1,004,711 946,019
Deferred Revenue 545 473 545 473 545
Total Current Liabilities 162,423 178,732 162,423 178,732 132,277
Total Liabilities 635,204 587,097 635,204 587,097 511,758
Stockholders' Equity 436,799 417,614 436,799 417,614 434,261
Total Liabilities and Stockholders' Equity 1,072,003 1,004,711 1,072,003 1,004,711 946,019
Restatement Adjustment [Member]          
Net Sales (5,025) (12,938) (34,123) 1,942  
Cost of Products Sold (3,825) (13,389) (29,705) (1,302)  
Gross Profit (1,200) 451 (4,418) 3,244  
Operating Income/(Loss) (1,200) 451 (4,418) 3,244  
Earnings/(Loss) Before Income Taxes (1,200) 451 (4,418) 3,244  
Income Tax (Benefit) Expense 2,150 843 919 1,932  
Net earnings $ (3,350) $ (392) $ (5,337) $ 1,312  
Earnings Per Common Share-Basic (in dollars per share) $ (0.34) $ (0.04) $ (0.55) $ 0.14  
Earnings Per Common Share-Diluted (in dollars per share) $ (0.34) $ (0.04) $ (0.54) $ 0.14  
Inventory $ 60,584 $ 43,077 $ 60,584 $ 43,077 30,879
Total Current Assets 60,584 43,077 60,584 43,077 30,879
Total Assets 62,234 49,035 62,234 49,035 32,249
Deferred Revenue 79,606 60,080 79,606 60,080 45,555
Total Current Liabilities 79,610 60,039 79,610 60,039 45,487
Total Liabilities 76,628 60,039 76,628 60,039 41,306
Stockholders' Equity (14,394) (11,004) (14,394) (11,004) (9,057)
Total Liabilities and Stockholders' Equity $ 62,234 $ 49,035 $ 62,234 $ 49,035 $ 32,249